UBS has revised its price target for Aemetis (AMTX, Financial), reducing it from $6.75 to $2.50 while maintaining a Buy rating on the stock. This adjustment comes in response to several market challenges, including uncertainties surrounding renewable identification numbers (RIN) prices and Aemetis's disappointing fourth-quarter earnings.
The firm notes concerns over RIN pricing into 2025 due to possible regulatory shifts that could impact the sector. Additionally, the outlook for the low carbon fuel standard is another factor contributing to the revised target. Despite these headwinds, UBS's continued Buy rating suggests a belief in the company's long-term potential and resilience.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 5 analysts, the average target price for Aemetis Inc (AMTX, Financial) is $11.75 with a high estimate of $28.00 and a low estimate of $2.00. The average target implies an upside of 632.09% from the current price of $1.61. More detailed estimate data can be found on the Aemetis Inc (AMTX) Forecast page.
Based on the consensus recommendation from 6 brokerage firms, Aemetis Inc's (AMTX, Financial) average brokerage recommendation is currently 2.5, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Aemetis Inc (AMTX, Financial) in one year is $6.93, suggesting a upside of 331.78% from the current price of $1.605. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Aemetis Inc (AMTX) Summary page.
